Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2012

Nov 28, 2012

32853_dirs_2012-11-28_e8d74d09-93e0-405d-9587-9fd36efae800.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2012-11-26

Reporting Person: Walder Fredric T (See Remarks)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-11-26 Common Stock M 9858 $4.4461 Acquired 9858 Direct
2012-11-26 Common Stock S 9858 $14.4995 Disposed 0 Direct
2012-11-27 Common Stock M 5587 $4.4461 Acquired 5587 Direct
2012-11-27 Common Stock S 5587 $14.3848 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-11-26 Employee Stock Option (Right to Buy) $4.4461 M 9858 Disposed 2020-08-26 Common Stock (9858) Direct
2012-11-27 Employee Stock Option (Right to Buy) $4.4461 M 5587 Disposed 2020-08-26 Common Stock (5587) Direct

Footnotes

F1: The sales reported by Mr. Walder were effected pursuant to a Rule 10b5-1 trading plan adopted on November 15, 2012.

F2: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $14.27 to $14.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $14.18 to $14.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F4: 25% of the shares subject to the Option vested on May 17, 2011 and 1/48 of the shares subject to the Option vest monthly thereafter.